Myriad Genetics Inc (MYGN)

Total asset turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	837,600	823,600	802,200	774,200	753,200	734,400	698,900	694,700	678,400	661,400	672,300	682,400	690,600	684,400	662,300	566,100	557,000	597,500	638,600	760,800
Total assets	US$ in thousands	1,027,600	1,081,300	1,085,100	1,110,500	1,146,500	1,149,100	1,187,200	1,169,300	1,198,700	1,212,000	1,210,200	1,255,400	1,320,700	1,335,900	1,360,300	1,336,900	1,418,800	1,444,500	1,404,600	1,446,700
Total asset turnover		0.82	0.76	0.74	0.70	0.66	0.64	0.59	0.59	0.57	0.55	0.56	0.54	0.52	0.51	0.49	0.42	0.39	0.41	0.45	0.53

December 31, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $837,600K ÷ $1,027,600K
= 0.82

Myriad Genetics Inc's total asset turnover has shown a generally increasing trend over the past few years, indicating improved efficiency in utilizing its assets to generate revenue. The ratio has consistently increased from 0.53 on March 31, 2020, to 0.82 on December 31, 2024. This suggests that the company is generating more revenue for each dollar of assets it holds.

The highest total asset turnover ratio was observed on December 31, 2024, at 0.82, indicating that the company generated $0.82 in revenue for every dollar of assets it had at the end of that period. This demonstrates the company's ability to effectively utilize its assets to generate sales.

Overall, the increasing trend in total asset turnover ratios reflects positively on Myriad Genetics Inc's operational efficiency and ability to generate revenue from its asset base.